Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | KCNK3 | O14649 | 2/20 | 0.39 |
| ▸ | CCNA2 | P20248 | 2/20 | 0.38 |
| ▸ | CDK2 | P24941 | 2/20 | 0.38 |
| ▸ | CCNA1 | P78396 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27117828 | 1.00 | L3MBTL1 (0.39) | L3MBTL1KCNK3CCNA2CDK2CCNA1 | |
| SCHEMBL31236969 | 0.92 | KCNK3 (0.41) | L3MBTL1KCNK3CCNA2CDK2CCNA1 | |
| SCHEMBL30759474 | 0.88 | MAPT (0.34) | L3MBTL1CCNA2CDK2CCNA1KDM4E | |
| SCHEMBL27117850 | 0.88 | MAPT (0.34) | L3MBTL1CCNA2CDK2CCNA1KDM4E | |
| SCHEMBL30759600 | 0.84 | CCNA2 (0.47) | L3MBTL1KCNK3CCNA2CDK2CCNA1 | |
| SCHEMBL27119351 | 0.84 | CCNA2 (0.47) | L3MBTL1KCNK3CCNA2CDK2CCNA1 | |
| SCHEMBL27118701 | 0.84 | CCNA2 (0.43) | L3MBTL1KCNK3CCNA2CDK2CCNA1 | |
| SCHEMBL17381607 | 0.82 | CCNA2 (0.43) | L3MBTL1CCNA2CDK2CCNA1ALDH1A1 | |
| SCHEMBL30759630 | 0.82 | L3MBTL1 (0.39) | L3MBTL1KCNK3CCNA2CDK2CCNA1 | |
| SCHEMBL29538955 | 0.82 | CCNA2 (0.43) | L3MBTL1CCNA2CDK2CCNA1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260008783-A1 | MODULATORS OF FSHR AND USES THEREOF | GEDEON RICHTER PLC (HU) | 2026-01-08 | — | — | US | disclosed |
| EP-4577206-A2 | NOVEL MODULATORS OF FSHR AND USES THEREOF | Celmatix Inc. (US) | 2025-07-02 | — | — | EP | disclosed |
| WO-2024044778-A2 | NOVEL MODULATORS OF FSHR AND USES THEREOF | CELMATIX INC. (US) | 2024-02-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260008783-A1 | MODULATORS OF FSHR AND USES THEREOF | FSHR, GNRHR, LHCGR | L3MBTL1 4638/4885KCNK3 2171/4885CCNA2 2070/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.